A recent study from Future Market Insights predicts the global bone densitometer devices market to witness a hike in revenues at a passive compound annual growth rate of 3.5% over the next decade. The company forecasts that the market for bone densitometer devices will be valued at $390.6 million, up from its current value of $277 million, by the end of 2026.
Driven primarily by rising incidences of osteoporosis and other bone-related disorders, the market will also be fuelled by the ensuing awareness about growing osteoporosis incidences, the report states. Increased emphasis on preventive healthcare, early diagnosis, and quality treatment are identified to be among the key factors spurring global demand. Aging, resulting in an almost threefold risk of acquiring wrist, hip, and vertebral osteoporosis, will remain a major market growth catalyst.
Moreover, the increasing prevalence of vitamin D and calcium deficiency disorders will also escalate the demand in near future. Burgeoning cancer prevalence is boosting the number of patients undergoing chemotherapy, which is expected to affect their bone density in the long run. Increasing integration of dual energy X-ray absorptiometry (DXA) into routine health check-ups will also escalate market growth over the forecast period.
North America will continue to represent the largest market for bone densitometer devices, followed by Western Europe and Asia Pacific. Axial bone densitometer devices will continue to gain higher traction, accounting for around 70% value share by 2026.
The peripheral bone densitometer segment is also likely to witness steady adoption, as it allows short scan time and lesser exposure to radiation. The United States will continue to dominate the North American market with nearly 75% revenue share of the region. Based on technology, the DXA segment is expected to remain dominant with nearly 65% share by 2026.
To access the report, visit Future Market Insights.
